← Eichor
Condition: Autologous Stem Cell Transplant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autologous Stem Cell Transplant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
Phase 3 · 1 location(s) · CUTISS AG · NCT06745557Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · 1 location(s) · David Bartlett, MD · NCT07192900a Single-arm, Single-center, Open Clinical Study
Phase N/A · 1 location(s) · Beijing Geekgene Technology Co., LTD · NCT06431100A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
EARLY_Phase 1 · 1 location(s) · Shanghai Cell Therapy Group Co.,Ltd · NCT06732232The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT06244264Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06305299Chemotherapy Supported by Autologous Hematopoietic Stem Cells
NA · 1 location(s) · Chongqing University Cancer Hospital · NCT05401162Amplification of Autologous Epidermal Cells to Repair Large Area Deep Wounds
NA · 1 location(s) · Yicheng Ma · NCT05882110Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients
Phase 1 · 1 location(s) · Mayo Clinic · NCT07317154Antegrade Autologous Blood Reinfusion After CPB
Phase N/A · 1 location(s) · Kocaeli City Hospital · NCT07420582Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With R
NA · 1 location(s) · Beijing Boren Hospital · NCT06983951Motiva Flora® Aesthetic Breast Recon® Clinical Study
NA · 4 location(s) · Establishment Labs · NCT06146231Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Phase 1/Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05981001REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Submandibular Gland Stem Cell Transplantation
Phase 1 · 1 location(s) · University Medical Center Groningen · NCT04593589Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP)
Phase N/A · 1 location(s) · Vastra Gotaland Region · NCT05363189Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06347068Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Thera
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06140966TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium
NA · 1 location(s) · Deutsches Herzzentrum Muenchen · NCT03600662Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Phase 2 · 18 location(s) · Canadian Cancer Trials Group · NCT05180097A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastati
Phase 1/Phase 2 · 1 location(s) · CuraCell TX AB · NCT07255664Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab
Phase 1/Phase 2 · 1 location(s) · Universitair Ziekenhuis Brussel · NCT03707808Hirschsprung's Advances; Working Towards Autologous tIssue therapIes
Phase N/A · 1 location(s) · Alder Hey Children's NHS Foundation Trust · NCT06590142Risk Stratification and MRD-driven Maintenance for MM After ASCT
NA · 4 location(s) · Peking University People's Hospital · NCT06697483Tunnel Widening in Augmented ACL Integration Via PrP Enriched Collected Autologous Bone vs Standard ACL Technique
NA · 1 location(s) · Schulthess Klinik · NCT05953051Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)
Phase 2 · 1 location(s) · Peking University · NCT06347653Evaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible fo
NA · 1 location(s) · Centre Hospitalier Henri Duffaut - Avignon · NCT06789003Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched Wit
Phase 2 · 1 location(s) · Minovia Therapeutics Ltd. · NCT06017869VitD3 Supplementation in Patients With Multiple Myeloma
EARLY_Phase 1 · 1 location(s) · Amany Keruakous, MD, MS. · NCT05846880
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.